From L-R: Benjamin and Sara Netanyahu, Ivanka Trump and Jared Kushner at the embassy opening. Photo: Israel Press Office /Handout/Anadolu Agency/Getty Images

Palestinian President Mahmoud Abbas has decided to recall the head of the PLO office in Washington in protest over the opening of the new U.S. embassy in Jerusalem.

Why it matters: This move further deepens the crisis between the U.S. and the Palestinian Authority. Since President Trump's December 6th announcement recognizing Jerusalem as the capital of Israel, Palestinian leadership has boycotted the White House and suspended almost all contacts with the Trump administration.

Where things stand:

  • The Palestinian boycott makes the White House ambition to launch a peace plan and new round of negotiations between Israel and the Palestinians in the upcoming months much more difficult to achieve.
  • Other than local contact with the U.S. consulate in Jerusalem and security and counter-terrorism cooperation with the CIA and the Pentagon, ties between Washington and Ramallah have been severed.
  • The Palestinian foreign ministry said in a statement that Husam Zomlot, the envoy, had already left the U.S. and will arrive in Ramallah tomorrow.

Go deeper

Trump pushes to expand ban against anti-racism training to federal contractors

Trump speaking at Moon Township, Penns., on Sept. 22. Photo: Mandel Ngan/AFP via Getty Images

President Trump announced late Tuesday that the White House attempt to halt federal agencies' anti-racism training would be expanded to block federal contractors from "promoting radical ideologies that divide Americans by race or sex."

Why it matters: The executive order appears to give the government the ability to cancel contracts if anti-racist or diversity trainings focused on sexual identity or gender are organized. The memo applies to executive departments and agencies, the U.S. military, federal contractors and federal grant recipients.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 9:30 p.m. ET: 31,467,508 — Total deaths: 967,881— Total recoveries: 21,583,915Map.
  2. U.S.: Total confirmed cases as of 9:30 p.m. ET: 6,890,662 — Total deaths: 200,710 — Total recoveries: 2,646,959 — Total tests: 96,612,436Map.
  3. Health: The U.S. reaches 200,000 coronavirus deaths — The CDC's crumbling reputation — America turns against coronavirus vaccine.
  4. Politics: Elected officials are failing us on much-needed stimulus.
  5. Business: Two-thirds of business leaders think pandemic will lead to permanent changes — Fed chair warns economy will feel the weight of expired stimulus.
  6. Sports: NFL fines maskless coaches.
Dan Primack, author of Pro Rata
3 hours ago - Economy & Business

GoodRx prices IPO at $33 per share, valued at $12.7 billion

Illustration: Sarah Grillo/Axios

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday night raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!